Video: Explaining kala azar-HIV coinfection
November 25, 2018Kala azar or visceral leishmaniasis a neglected tropical disease and the second-largest parasitic killer in the world. India accounts for over 30% of the total kala azar cases in the world. 80% of these cases occur in Bihar. Since 2007,...
Read more
Bihar: On the frontline of treating kala azar-HIV co-infection
September 19, 2018Kala azar is one of the most dangerous neglected tropical diseases in the world. It is spread to humans by bites from infected female sand flies and attacks the immune system. While cases of the disease are declining steadily, kala...
Read more
Bihar: "I try to bring hope to patients living with kala azar-HIV co-infection"
September 18, 2018Name : Designation : Interview conducted and written by Kavitha Devadas for MSF Kala azar is one of the most dangerous neglected tropical diseases in the world. It is spread to humans by bites from infected female sand flies and...
Read more
National Doctors’ Day: “Treating the most vulnerable in the most critical situations”
July 4, 2018Name : Designation : 1 July is observed in India as National Doctors’ Day. To mark the occasion we asked three MSFers how they became doctors, and what it means to be a doctor without borders. Shazeer Majeed As...
Read more
Uttar Pradesh: "Hepatitis C is more than a disease"
March 2, 2018Name : Designation : Sevantee Ghosh, a medical doctor from Kolkata, has been working with MSF’s hepatitis C project in Meerut, Uttar Pradesh, since January 2017. In this piece, she looks back on a year of treating hepatitis C. I...
Read more
MSF’s hepatitis C project in Uttar Pradesh: One year, 1,198 patients
March 2, 2018In January 2017, Doctors Without Borders/Médecins Sans Frontiéres (MSF), in collaboration with the National Health Mission in Uttar Pradesh, started a pilot hepatitis project in Meerut city. Uttar Pradesh is one of the largest Indian states and has an estimated...
Read more
MSF: India’s decision to give Pfizer unmerited patent on lifesaving pneumonia vaccine limits access for children globally
November 20, 2017At High Court of Delhi hearing tomorrow, Doctors Without Borders/Médecins Sans Frontières (MSF) will urge India to remain the “pharmacy of the developing world” and rethink decision that solidifies Pfizer monopoly on critical pneumonia vaccine New York/ New Delhi, November 20, 2017 —...
Read more
Antibiotic Resistance: Drug-resistant infections are a looming challenge around the world
November 15, 2017Since 2015, Doctors Without Borders/ Médecins Sans Frontières (MSF) has been working on antibiotic resistance in collaboration with the health authorities in West Bengal, India. As the world discusses this growing challenge during the Antibiotic Awareness Week (November 12 to 18),...
Read more
Delhi: “There needs to be a shift in the individual and in society to say no to violence”
October 10, 2017Name : Designation : Virginia Lee is a counsellor from Australia who recently spent seven months working as a mental health coordinator in a community clinic in Delhi. The clinic offers medical and psychological care to survivors of domestic and...
Read more
Chhattisgarh: Medicine on the margins
August 30, 2017How doctors take healthcare to people who would otherwise struggle to access it Nearly 400km south of Raipur, the capital of Chhattisgarh, lies a town called Bijapur. It is the kind of town that now survives only as a memory...
Read more
Indian patent office delivers major blow to affordable pneumonia vaccine hopes
August 22, 2017Geneva/New York/New Delhi, 22 August 2017 – Hopes for improved access to an affordable pneumococcal conjugate vaccine (PCV) that safeguards both children and adults from pneumonia were dealt a major blow after the Indian patent office granted a patent to...
Read more
Antibiotics: Handle with care
May 4, 2017Name : Designation : Imagine a world where a small finger prick can get fatally infected or an elective caesarean surgical wound fails to heal at all. One may immediately connect this with the pre-antibiotic era though some experts...
Read more
